We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+5.93%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$11B
AUM Growth
+$603M
Cap. Flow
+$252M
Cap. Flow %
2.29%
Top 10 Hldgs %
40.89%
Holding
1,480
New
91
Increased
1,128
Reduced
222
Closed
37

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$18.5M
2
AAPL icon
Apple
AAPL
+$15.2M
3
AMZN icon
Amazon
AMZN
+$14.8M
4
NVDA icon
NVIDIA
NVDA
+$11.5M
5
COP icon
ConocoPhillips
COP
+$5.93M

Sector Composition

Rank Sector Weight
1 Technology 36.55%
2 Consumer Discretionary 12.67%
3 Financials 11.51%
4 Communication Services 10.36%
5 Healthcare 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUBO icon
1426
FuboTV Inc
FUBO
$305M
$29K ﹤0.01%
1,917
+308
+19% +$5.65K
URG
1427
Ur-Energy
URG
$609M
$28.5K ﹤0.01%
24,765
+3,567
+17% +$4.4K
LESL icon
1428
Leslie's
LESL
$4.99M
$28.4K ﹤0.01%
636
+55
+9% +$2.92K
NXDR
1429
Nextdoor Holdings
NXDR
$897M
$28.2K ﹤0.01%
11,891
+694
+6% +$1.72K
AKBA icon
1430
Akebia Therapeutics
AKBA
$260M
$27.1K ﹤0.01%
14,289
+588
+4% +$1.02K
CIG icon
1431
CEMIG Preferred Shares
CIG
$5.64B
$26K ﹤0.01%
14,707
+862
+6% +$1.67K
SMRT icon
1432
SmartRent
SMRT
$261M
$22.6K ﹤0.01%
12,943
+687
+6% +$1.15K
CERS icon
1433
Cerus
CERS
$548M
$21.9K ﹤0.01%
14,229
+2,995
+27% +$5.15K
TSHA icon
1434
Taysha Gene Therapies
TSHA
$1.94B
$20.6K ﹤0.01%
11,925
+1,056
+10% +$2.19K
SLDP icon
1435
Solid Power
SLDP
$543M
$19.7K ﹤0.01%
10,399
+300
+3% +$371
MVIS icon
1436
Microvision
MVIS
$57.5M
$19.2K ﹤0.01%
976
+85
+10% +$1.34K
OCGN icon
1437
Ocugen
OCGN
$465M
$14.9K ﹤0.01%
18,462
+1,711
+10% +$1.57K
REI icon
1438
Ring Energy
REI
$383M
$13.7K ﹤0.01%
+10,081
New +$15.1K
NKTR icon
1439
Nektar Therapeutics
NKTR
$2.55B
$11.1K ﹤0.01%
793
+73
+10% +$1.29K
IAUX
1440
i-80 Gold Corp
IAUX
$1.66B
$10.6K ﹤0.01%
21,951
+1,941
+10% +$1.57K
XFOR icon
1441
X4 Pharmaceuticals
XFOR
$419M
$7.89K ﹤0.01%
+359
New +$5.72K
LYEL icon
1442
Lyell Immunopharma
LYEL
$358M
$7.04K ﹤0.01%
550
+47
+9% +$932
LCTX icon
1443
Lineage Cell Therapeutics
LCTX
$293M
$5.25K ﹤0.01%
+10,456
New +$7.68K
ACLS icon
1444
Axcelis
ACLS
$3.78B
-2,138
Closed -$224K
AMPH icon
1445
Amphastar Pharmaceuticals
AMPH
$931M
-4,497
Closed -$218K
AZTA icon
1446
Azenta
AZTA
$1.47B
-5,721
Closed -$277K
BLUE
1447
DELISTED
bluebird bio
BLUE
-592
Closed -$6.15K
CRI icon
1448
Carter's
CRI
$1.22B
-4,488
Closed -$292K
CRK icon
1449
Comstock Resources
CRK
$4.29B
-10,538
Closed -$117K
CWT icon
1450
California Water Service
CWT
$3.1B
-3,755
Closed -$204K

Similar funds

Xponance's Q4 2024 Portfolio in Review

As of Q4 2024, Xponance held 1,480 positions worth $11B, up 5.8% from $10.4B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Xponance's Q4 2024 filing shows 91 new, 1,128 increased, 222 reduced and 37 closed positions. Its largest new stake was Flex: 28,036 shares worth $1.08M. The largest sale was Entergy, an estimated $4.63M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 36% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Xponance's largest Q4 2024 buy was Flex: 28,036 shares worth $1.08M.
  • Xponance added most to Microsoft in Q4 2024, an estimated $18.5M increase.
  • Xponance's biggest Q4 2024 reduction was Entergy, cutting an estimated $4.63M.
  • Xponance fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $3.72M.
  • Xponance's ten largest holdings make up 41% of its $11B portfolio in Q4 2024.
  • Xponance opened 91 new positions and closed 37 in Q4 2024.
  • Xponance's portfolio value rose 5.8% quarter-over-quarter to $11B.

Based on Xponance's 13F filing for Q4 2024, filed 11 Feb 2025.